Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors

Ajay K. Gupta, Hani Jneid, Daniel Addison, Hossein Ardehali, Amelia K. Boehme, Sanket Borgaonkar, Romain Boulestreau, Kevin Clerkin, Nicolas Delarche, Holli A. DeVon, Isabella M. Grumbach, Jose Gutierrez, Daniel A. Jones, Vikas Kapil, Carmela Maniero, Amgad Mentias, Pamela S. Miller, Sher May Ng, Jai D. Parekh, Reynaldo H. SanchezKonrad Teodor Sawicki, Anneline S J M te Riele, Carol Ann Remme, Barry London

Research output: Contribution to journalReview articleAcademicpeer-review

53 Citations (Scopus)

Abstract

Coronavirus Disease 2019 (COVID-19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection. In addition, we will also address various issues related to the safety of healthcare workers and the ethical issues related to patient care in this pandemic.

Original languageEnglish
Pages (from-to)e017013
JournalJournal of the American Heart Association
Volume9
Issue number12
Early online date29 Apr 2020
DOIs
Publication statusPublished - 16 Jun 2020

Keywords

  • COVID‐19
  • Cardiovascular disease
  • Coronavirus disease 2019
  • SARS‐CoV‐2
  • cardiovascular risk factors
  • management
  • treatment

Cite this